Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
Narula N, Peerani F, Meserve J, Kochhar G, Chaudrey K, Hartke J, Chilukuri P, Koliani-Pace J, Winters A, Katta L, Shmidt E, Hirten R, Faleck D, Parikh MP, Whitehead D, Boland BS, Singh S, Sagi SV, Fischer M, Chang S, Barocas M, Luo M, Lasch K, Bohm M, Lukin D, Sultan K, Swaminath A, Hudesman D, Gupta N, Shen B, Kane S, Loftus EV, Siegel CA, Sands BE, Colombel JF, Sandborn WJ, Dulai PS. Narula N, et al. Among authors: faleck d. Am J Gastroenterol. 2018 Dec;113(12):696. doi: 10.1038/s41395-018-0401-4. Am J Gastroenterol. 2018. PMID: 30390030 Free PMC article.
Enterocolitis due to immune checkpoint inhibitors: a systematic review.
Soularue E, Lepage P, Colombel JF, Coutzac C, Faleck D, Marthey L, Collins M, Chaput N, Robert C, Carbonnel F. Soularue E, et al. Among authors: faleck d. Gut. 2018 Nov;67(11):2056-2067. doi: 10.1136/gutjnl-2018-316948. Epub 2018 Aug 21. Gut. 2018. PMID: 30131322 Review.
Reply to Y. Inagaki et al.
Abu-Sbeih H, Faleck DM, Dougan M, Wang Y. Abu-Sbeih H, et al. J Clin Oncol. 2020 May 20;38(15):1749-1750. doi: 10.1200/JCO.20.00295. Epub 2020 Apr 6. J Clin Oncol. 2020. PMID: 32250720 No abstract available.
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study.
Zou F, Faleck D, Thomas A, Harris J, Satish D, Wang X, Charabaty A, Ernstoff MS, Glitza Oliva IC, Hanauer S, McQuade J, Obeid M, Shah A, Richards DM, Sharon E, Wolchok J, Thompson J, Wang Y. Zou F, et al. Among authors: faleck d. J Immunother Cancer. 2021 Nov;9(11):e003277. doi: 10.1136/jitc-2021-003277. J Immunother Cancer. 2021. PMID: 34789551 Free PMC article.
IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience.
Shirwaikar Thomas A, Lee SE, Shatila M, De Toni EN, Török HP, Ben Khaled N, Powell N, Weight R, Faleck DM, Wang Y. Shirwaikar Thomas A, et al. Am J Gastroenterol. 2023 Sep 1;118(9):1679-1683. doi: 10.14309/ajg.0000000000002332. Epub 2023 Jun 22. Am J Gastroenterol. 2023. PMID: 37216614 Free PMC article.
51 results